tiprankstipranks

Braden Michael Leonard Insider Profile

25 Followers
Braden Michael Leonard, Ten Percent Owner at Outset Medical, holds 2.52M shares in Outset Medical (Ticker: OM), holds 13.95M shares in Aclaris Therapeutics (Ticker: ACRS), holds 2.15M shares in Adverum Biotechnologies (Ticker: ADVM). Most recently, Braden Michael Leonard Bought ― shares of Outset Medical on May 18, 2026 for an estimated value of $1.61M.
tipranks
Braden Michael Leonard

Braden Michael Leonard
Outset Medical (OM)
Ten Percent Owner

Ranked #90,250 out of 108,921 Corporate Insiders

Profitable Transactions

49%
41 out of 83 Profitable Transactions

Average Return

-5.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$695M
58.01%
17.06%
12.16%
6.68%
6.08% Others
A breakdown of Braden Michael Leonard's holdings

Insider Roles

Disc Medicine
(IRON)
Ten Percent Owner
Enliven Therapeutics
(ELVN)
Ten Percent Owner
Aclaris Therapeutics
(ACRS)
Ten Percent Owner
BuildABear Workshop
(BBW)
Director
+7 other positions
Roles that Braden Michael Leonard holds in companies

Most Profitable Insider Trade

Stock:
Enliven Therapeutics
(ELVN)
Rating:Informative Buy
Date:Jun 21, 2022 - Jun 21, 2023
Return:+244.40%
The most profitable trade made by Braden Michael Leonard

Braden Michael Leonard's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Outset Medical
May 18, 2026
Ten Percent Owner
Informative Buy
1.61M
$8.74M
BuildABear Workshop
Sep 26, 2017
Director
Informative Sell
429.95K
$46.45M
Disc Medicine
Oct 27, 2022
Ten Percent Owner
Informative Sell
47.02K
$403.22M
Enliven Therapeutics
Jan 04, 2023
Ten Percent Owner
Informative Sell
5.00M
$118.61M
Retractable Technologies
Dec 29, 2022
Ten Percent Owner
Informative Sell
4.80M
$753.25K
Astrotech
Oct 07, 2025
Ten Percent Owner
Informative Sell
1.62M
$0.00
MTCR
Metacrine
Dec 21, 2022
Informative Buy
107.14K
$3.93M
STSA
Satsuma Pharmaceuticals
Nov 23, 2022
Informative Buy
106.50K
$7.25M
CYT
Cyteir Therapeutics
Mar 19, 2024
Informative Buy
342.47K
$11.49M
Tectonic Therapeutic
Jun 25, 2024
Former 10% owner of AVROBIO
Uninformative Buy
$13.18M
OnKure Therapeutics
Oct 09, 2024
Former 10% owner of RPHM
Uninformative Buy
$1.52M
Aclaris Therapeutics
Apr 27, 2026
Ten Percent Owner
Informative Sell
1.36M
$84.54M
ADVM
Adverum Biotechnologies
Dec 05, 2025
Informative Sell
2.20M
$9.37M
AN2 Therapeutics, Inc.
Jun 16, 2025
Ten Percent Owner
Informative Sell
218.00K
$18.04M
TLIS
Talis Biomedical
Sep 09, 2024
Informative Buy
44.14K
$706.31K
Prophase Labs
Nov 07, 2014
Ten Percent Owner
Informative Buy
86.68K
$39.48K
List of latest transactions for each holding click on a transaction to see Braden Michael Leonard's performance on stock

Braden Michael Leonard insider profile FAQ

What is the percentage of profitable transactions made by Braden Michael Leonard?
The percentage of profitable transactions made by Braden Michael Leonard is 49%.
    What is the average return per transaction made by Braden Michael Leonard?
    The average return per transaction made by Braden Michael Leonard is -5.70%.
      What stocks does Braden Michael Leonard hold?
      Braden Michael Leonard holds: OM, BBW, IRON, ELVN, RVP, ASTC, MTCR, STSA, CYT, TECX, OKUR, ACRS, ADVM, ANTX, TLIS, PRPH stocks.
        What was Braden Michael Leonard’s latest transaction?
        Braden Michael Leonard latest transaction was an Informative Buy of $1.61M.
          What was Braden Michael Leonard's most profitable transaction?
          Braden Michael Leonard’s most profitable transaction was an Informative Buy of ELVN stock on June 21, 2022. The return on the trade was 244.40%.
            What is Braden Michael Leonard's role in Outset Medical?
            Braden Michael Leonard's role in Outset Medical is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.